Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vardenafil hydrochloride trihydrate (BAY38-9456) is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 64.00 | |
25 mg | In stock | $ 127.00 | |
50 mg | In stock | $ 197.00 | |
100 mg | In stock | $ 313.00 | |
200 mg | In stock | $ 468.00 | |
500 mg | In stock | $ 753.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 57.00 |
Description | Vardenafil hydrochloride trihydrate (BAY38-9456) is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively. |
Targets&IC50 | PDE5:0.7 nM, PDE1:180 nM |
In vitro | Vardenafil specifically inhibits the hydrolysis of cGMP by PDE5 with an IC50 of 0.7 nM (6.6 nM). Vardenafil significantly enhances the SNP-induced relaxation of human trabecular smooth muscle at 3 nM (10 nM). Vardenafil also significantly potentiates both ACh-induced and transmural electrical stimulation-induced relaxation of trabecular smooth muscle. Vardenafil (100 mM) increases cyclic GMP levels in rat hippocampal slices. Vardenafil, tadalafil, and Sildenafil each competitively inhibit cGMP hydrolysis by phosphodiesterase-5 (PDE5), thereby fostering cGMP accumulation and relaxation of vascular smooth muscle. |
In vivo | Vardenafil dose-dependently potentiates erectile responses to intravenously administered sodium nitroprusside in rabbit. Vardenafil (3 mg/kg, p.o.) results in an improved object discrimination performance in rats. Vardenafil (30 mg/L, p.o.) increases both iNOS and proliferating cell nuclear antigen expression (SM cell replication) in rats, with normalization of the dynamic infusion cavernosometry drop rate and SM/collagen ratio. Vardenafil induces powerful preconditioning-like cardioprotective effect against ischemia/reperfusion injury through the opening of mitochondrial K(ATP) channels in the heart of rabbit. Vardenafil protects the ischemic myocardium against reperfusion injury through a mechanism dependent on mitochondrial K(ATP) channel opening. |
Synonyms | Vardenafil HCl Trihydrate, BAY38-9456 |
Molecular Weight | 579.11 |
Formula | C23H32N6O4S·HCl·3H2O |
CAS No. | 330808-88-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 93 mg/mL (160.6 mM)
H2O: 10 mg/mL (17.27 mM)
Ethanol: 16 mg/mL (27.6 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vardenafil hydrochloride trihydrate 330808-88-3 Metabolism PDE Vardenafil HCl hepatitis Zucker diabetic fatty (ZDF) rats Inhibitor dysfunction erectile smooth Vardenafil HCl Trihydrate Vardenafil hydrochloride muscle Endogenous Metabolite pharmacokinetics selective BAY38-9456 inhibit Vardenafil Hydrochloride erectile dysfunction Vardenafil hydrochloride Trihydrate impotence Vardenafil diabetes Phosphodiesterase (PDE) stimulation cGMP inhibitor